1McNicol E,Horowicz-Mehler N,Fisk RA,et al. Management ofopioid side effects in cancer-related and chronic noncancer pain: asystematic review. J Pain, 2003,4(5) :231-256.
2Individual variation in sensitivity to morphine and the need to switchto an alternative opioid in cancer patients. Support Care Cancer,2006,14(1):56-64.
3King SJ, Reid C, Forbes K, et al. A systematic review of oxyc- odone in the management of cancer pain. Palliat Med, 2011,25 (5) ..454-470.
4Takehara Y, Satoh T, Nishizawa A, et al. Antitumor effects of inactivated Sendai virus particles with an IL-2 gene on anglo- sarcoma. Clin Immunol, 2013,149 (1) : 1-10.
5Narita M, Nakamura A, Ozaki M, et al. Comparative pharmaco- logical profiles of morphine and oxycodone under a neuropathic pain-like state in mice., evidence for less sensitivity to morphine ,2008, 33 (5):1097-1112.
6Katz J, Clarke H, Seltzer Z. Review article: Preventive anal- gesia: quo vadimus? Anesth Analg, 2011, 113 (5): 1242-1253.
7Margaryan G, Mattioli C, Mladinic M, et al. Neuroprotec- tion of locomotor networks after experimental injury to the neonatal rat spinal cord in vitro. Neuroscience, 2010, 165 (3) : 996-1010.
8Neuss H, Koplin G, Haase O, et al. Preemptive analgesia reduces pain after radical axillary lymph node dissection. J Surg Res, 2010,162(1) :88-94.
9Kokki M, Broms S, Eskelien M, et al. The analgesic concen- tration of oxycodone with co-administration of paracetamol-a dose-finding study in adult patients undergoing laparoscopic cholecysteetomy. Basic Clin Pharmacol Toxicol, 2012, 111 (6) : 391-395.
